BioCardia Reports First Quarter 2024 Business Highlights and Financial Results SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results BioCardia®, Inc. today reported financial results for the year ended December 31, 2023